HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masayoshi Kage Selected Research

4-phenylbutyric acid (Buphenyl)

11/2019Effect of food on the pharmacokinetics and therapeutic efficacy of 4-phenylbutyrate in progressive familial intrahepatic cholestasis.
6/2016Effects of 4-phenylbutyrate therapy in a preterm infant with cholestasis and liver fibrosis.
2/2016Successful treatment with 4-phenylbutyrate in a patient with benign recurrent intrahepatic cholestasis type 2 refractory to biliary drainage and bilirubin absorption.
5/2014Improved liver function and relieved pruritus after 4-phenylbutyrate therapy in a patient with progressive familial intrahepatic cholestasis type 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masayoshi Kage Research Topics

Disease

63Neoplasms (Cancer)
01/2022 - 10/2003
18Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2016 - 06/2009
16Fibrosis (Cirrhosis)
01/2022 - 06/2007
13Non-alcoholic Fatty Liver Disease
01/2022 - 09/2005
12Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 07/2012
10Breast Neoplasms (Breast Cancer)
01/2017 - 05/2006
9Colorectal Neoplasms (Colorectal Cancer)
07/2016 - 04/2011
9Lung Neoplasms (Lung Cancer)
08/2014 - 09/2009
8Liver Diseases (Liver Disease)
05/2018 - 04/2010
8Hepatocellular Carcinoma (Hepatoma)
03/2015 - 10/2003
7Cholestasis
01/2022 - 11/2006
7Neoplasm Metastasis (Metastasis)
07/2014 - 06/2008
6Infections
08/2015 - 04/2007
5Carcinoma (Carcinomatosis)
10/2015 - 04/2005
4Pruritus (Itching)
01/2022 - 08/2012
4Jaundice (Icterus)
01/2022 - 08/2012
4Inflammation (Inflammations)
06/2020 - 06/2007
4Pancreatic Neoplasms (Pancreatic Cancer)
10/2016 - 06/2006
4Chronic Hepatitis C
08/2015 - 04/2003
4Hepatitis
10/2014 - 11/2006
4Stomach Neoplasms (Stomach Cancer)
05/2013 - 08/2010
3Intrahepatic Cholestasis
01/2022 - 02/2016
3Fatty Liver
11/2021 - 04/2010
3progressive familial intrahepatic 1 Cholestasis
11/2019 - 05/2014
3Carcinogenesis
09/2016 - 06/2012
3Thrombocytopenia (Thrombopenia)
03/2015 - 01/2013
3Adenocarcinoma
11/2014 - 06/2008
3Chronic Hepatitis B
02/2010 - 09/2008
2Esophageal Squamous Cell Carcinoma
10/2016 - 06/2010
2Hypersplenism (Anemia, Splenic)
03/2015 - 10/2014
2Adenocarcinoma of Lung
11/2014 - 02/2014
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2014 - 08/2003
2Lymphatic Metastasis
01/2014 - 05/2012
2Hypertension (High Blood Pressure)
01/2014 - 01/2013

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
10/2016 - 08/2003
15ErbB Receptors (EGF Receptor)IBA
10/2016 - 01/2008
11Biomarkers (Surrogate Marker)IBA
05/2018 - 09/2009
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2012
7Gefitinib (Iressa)FDA Link
10/2013 - 01/2008
6EnzymesIBA
01/2019 - 06/2007
6Biological ProductsIBA
10/2016 - 07/2012
6DNA (Deoxyribonucleic Acid)IBA
07/2016 - 06/2010
6Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2013 - 01/2008
5Insulin (Novolin)FDA Link
01/2022 - 08/2004
5Member 11 Subfamily B ATP Binding Cassette TransporterIBA
01/2022 - 02/2016
5Pharmaceutical PreparationsIBA
11/2019 - 01/2008
5Transcription Factors (Transcription Factor)IBA
01/2017 - 03/2009
5Peptides (Polypeptides)IBA
05/2016 - 10/2013
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
08/2015 - 08/2011
5AntibodiesIBA
11/2014 - 06/2010
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014 - 06/2009
5Indicators and Reagents (Reagents)IBA
04/2013 - 01/2008
4Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2022 - 12/2011
44-phenylbutyric acid (Buphenyl)FDA Link
11/2019 - 05/2014
4Carrier Proteins (Binding Protein)IBA
05/2018 - 03/2009
4Monoclonal AntibodiesIBA
10/2016 - 11/2014
4Fluorine-18IBA
10/2016 - 07/2010
4MucinsIBA
11/2014 - 04/2012
4Phosphotransferases (Kinase)IBA
08/2014 - 06/2009
3Prednisolone (Predate)FDA LinkGeneric
01/2022 - 03/2010
3Bile Acids and Salts (Bile Acids)IBA
01/2022 - 02/2016
3Transaminases (Aminotransferases)IBA
01/2022 - 08/2004
3Keratin-18 (Keratin 18)IBA
11/2021 - 01/2017
3Estrogen ReceptorsIBA
01/2017 - 01/2006
3Therapeutic UsesIBA
06/2016 - 01/2013
3LigandsIBA
03/2016 - 06/2012
3InterferonsIBA
08/2015 - 04/2003
3CateninsIBA
07/2012 - 07/2011
3Small Interfering RNA (siRNA)IBA
05/2012 - 03/2008
3VimentinIBA
08/2010 - 11/2003
3Lamivudine (Epivir)FDA Link
02/2010 - 04/2007
3entecavirFDA Link
02/2010 - 09/2008
3Estrogen Receptor alphaIBA
03/2008 - 05/2006
2Alanine Transaminase (SGPT)IBA
08/2021 - 08/2015
2Butyric Acid (Butanoic Acid)IBA
08/2021 - 09/2011
2wisteria lectinIBA
05/2018 - 07/2015
2BilirubinIBA
06/2017 - 02/2016
2Formaldehyde (Formol)FDA Link
07/2016 - 02/2014
2Cancer VaccinesIBA
05/2016 - 10/2013
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2015 - 05/2015
2Ribavirin (Virazole)FDA LinkGeneric
08/2015 - 02/2007
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2015 - 10/2012
2Phenobarbital (Luminal)FDA Link
07/2015 - 11/2002
2Anaplastic Lymphoma KinaseIBA
05/2015 - 11/2014
2Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
10/2014 - 07/2010
2Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2014 - 09/2010
2Immunoglobulin G (IgG)IBA
10/2014 - 07/2014
2matrigelIBA
01/2014 - 06/2006
2Bile Pigments (Bilin)IBA
01/2014 - 04/2005
2Trastuzumab (Herceptin)FDA Link
05/2013 - 01/2008
2Lapatinib (GW572016)FDA Link
05/2013 - 01/2008
2locked nucleic acidIBA
01/2013 - 10/2011
2Peptide Nucleic AcidsIBA
01/2013 - 10/2011

Therapy/Procedure

21Therapeutics
01/2017 - 02/2007
8Drug Therapy (Chemotherapy)
08/2015 - 06/2009
4Hepatectomy
07/2017 - 06/2007
3Splenectomy
03/2015 - 01/2013
2Gastrectomy
10/2022 - 04/2013
2Immunotherapy
12/2014 - 07/2014
2Denervation
01/2014 - 01/2013